Figure 2
From: Pan-cancer and multi-omics analyses reveal the diagnostic and prognostic value of BAZ2B in cancer
Expression of BAZ2B protein in different tumors. (A–F) BAZ2B protein expression in BRCA, HNSC, PAAD, GBM, LIHC, and UCEC was analyzed based on CPTAC data, along with immunohistochemical (IHC) analysis of BAZ2B protein in tumor versus normal tissues from the HPA database. (G–I) The relationship between BAZ2B expression levels and pathological stages was explored using the UALCAN database. (J–K) Differences in BAZ2B protein phosphorylation levels between tumor and normal tissues in BRCA and HNSC were analyzed using the CPTAC module. *: P < 0.05; **: P < 0.01; ***: P < 0.001.
